PetVivo (PETV) Competitors

$0.78 0.00 (0.00%)

As of 05/22/2026 12:56 PM Eastern

PETV vs. NYXH, INO, VANI, LAKE, and SPAI

Should you buy PetVivo stock or one of its competitors? MarketBeat compares PetVivo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PetVivo include Nyxoah (NYXH), Inovio Pharmaceuticals (INO), Vivani Medical (VANI), Lakeland Industries (LAKE), and Safe Pro Group (SPAI). These companies are all part of the "medical equipment" industry.

How does PetVivo compare to Nyxoah?

PetVivo (NASDAQ:PETV) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

In the previous week, Nyxoah had 2 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for Nyxoah and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.67 beat Nyxoah's score of 0.00 indicating that PetVivo is being referred to more favorably in the media.

Company	Overall Sentiment
PetVivo	Positive
Nyxoah	Neutral

PetVivo has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market.

24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Nyxoah has a consensus price target of $7.67, indicating a potential upside of 167.13%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

PetVivo has higher earnings, but lower revenue than Nyxoah. PetVivo is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	26.92	-$10.95M	-$0.38	N/A
Nyxoah	$11.33M	9.82	-$101.92M	-$2.48	N/A

Nyxoah has a net margin of -543.21% compared to PetVivo's net margin of -902.82%. Nyxoah's return on equity of -163.73% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Nyxoah	-543.21%	-163.73%	-80.24%

Summary

Nyxoah beats PetVivo on 11 of the 16 factors compared between the two stocks.

How does PetVivo compare to Inovio Pharmaceuticals?

Inovio Pharmaceuticals (NASDAQ:INO) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

PetVivo has higher revenue and earnings than Inovio Pharmaceuticals. PetVivo is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inovio Pharmaceuticals	$60K	1,851.08	-$84.95M	-$1.45	N/A
PetVivo	$1.05M	26.92	-$10.95M	-$0.38	N/A

Inovio Pharmaceuticals has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 1.7% of Inovio Pharmaceuticals shares are held by company insiders. Comparatively, 10.8% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Inovio Pharmaceuticals had 5 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for Inovio Pharmaceuticals and 0 mentions for PetVivo. Inovio Pharmaceuticals' average media sentiment score of 0.98 beat PetVivo's score of 0.67 indicating that Inovio Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Inovio Pharmaceuticals	Positive
PetVivo	Positive

Inovio Pharmaceuticals has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Inovio Pharmaceuticals' return on equity of -489.79% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inovio Pharmaceuticals	N/A	-489.79%	-95.40%
PetVivo	-902.82%	-4,813.07%	-281.78%

Inovio Pharmaceuticals presently has a consensus price target of $4.50, suggesting a potential upside of 233.33%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe Inovio Pharmaceuticals is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inovio Pharmaceuticals	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Inovio Pharmaceuticals beats PetVivo on 12 of the 16 factors compared between the two stocks.

How does PetVivo compare to Vivani Medical?

PetVivo (NASDAQ:PETV) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Vivani Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Vivani Medical's return on equity of -264.04% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Vivani Medical	N/A	-264.04%	-79.85%

PetVivo has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

PetVivo has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	26.92	-$10.95M	-$0.38	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A

In the previous week, Vivani Medical had 3 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Vivani Medical and 0 mentions for PetVivo. Vivani Medical's average media sentiment score of 1.53 beat PetVivo's score of 0.67 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
PetVivo	Positive
Vivani Medical	Very Positive

Vivani Medical has a consensus target price of $3.50, suggesting a potential upside of 191.67%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Vivani Medical beats PetVivo on 10 of the 15 factors compared between the two stocks.

How does PetVivo compare to Lakeland Industries?

PetVivo (NASDAQ:PETV) and Lakeland Industries (NASDAQ:LAKE) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Lakeland Industries has a net margin of -13.14% compared to PetVivo's net margin of -902.82%. Lakeland Industries' return on equity of -9.57% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Lakeland Industries	-13.14%	-9.57%	-6.06%

PetVivo has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Lakeland Industries has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market.

Lakeland Industries has a consensus price target of $15.20, suggesting a potential upside of 45.73%. Given Lakeland Industries' stronger consensus rating and higher probable upside, analysts clearly believe Lakeland Industries is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

PetVivo has higher earnings, but lower revenue than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	26.92	-$10.95M	-$0.38	N/A
Lakeland Industries	$192.65M	0.53	-$25.31M	-$2.58	N/A

In the previous week, Lakeland Industries had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Lakeland Industries and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.67 beat Lakeland Industries' score of 0.00 indicating that PetVivo is being referred to more favorably in the media.

Company	Overall Sentiment
PetVivo	Positive
Lakeland Industries	Neutral

24.5% of PetVivo shares are held by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 3.4% of Lakeland Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Lakeland Industries beats PetVivo on 10 of the 16 factors compared between the two stocks.

How does PetVivo compare to Safe Pro Group?

PetVivo (NASDAQ:PETV) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Safe Pro Group has a consensus target price of $10.00, suggesting a potential upside of 136.41%. Given Safe Pro Group's stronger consensus rating and higher possible upside, analysts plainly believe Safe Pro Group is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Safe Pro Group	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.60

PetVivo has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3, meaning that its stock price is 200% more volatile than the broader market.

Safe Pro Group has a net margin of -800.91% compared to PetVivo's net margin of -902.82%. Safe Pro Group's return on equity of -119.17% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Safe Pro Group	-800.91%	-119.17%	-107.17%

PetVivo has higher revenue and earnings than Safe Pro Group. Safe Pro Group is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	26.92	-$10.95M	-$0.38	N/A
Safe Pro Group	$610K	144.86	-$14.32M	-$0.71	N/A

24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 54.8% of Safe Pro Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Safe Pro Group had 12 more articles in the media than PetVivo. MarketBeat recorded 12 mentions for Safe Pro Group and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.67 beat Safe Pro Group's score of 0.43 indicating that PetVivo is being referred to more favorably in the media.

Company	Overall Sentiment
PetVivo	Positive
Safe Pro Group	Neutral

Summary

Safe Pro Group beats PetVivo on 11 of the 17 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PETV vs. The Competition

Export

Metric	PetVivo	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$28.16M	$53.33M	$6.46B	$12.34B
Dividend Yield	N/A	1.08%	2.76%	5.28%
P/E Ratio	-1.73	18.68	20.99	25.66
Price / Sales	26.92	37.51	559.58	86.31
Price / Cash	N/A	18.87	43.49	56.67
Price / Book	-26.00	16.15	10.44	7.14
Net Income	-$10.95M	-$20.25M	$3.57B	$335.98M
7 Day Performance	-2.35%	2.27%	6.37%	4.11%
1 Month Performance	-2.38%	-12.00%	3.51%	2.52%
1 Year Performance	-2.50%	-2.39%	34.10%	35.04%

PetVivo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PETV PetVivo	N/A	$0.78 flat	N/A	-2.5%	$28.16M	$1.05M	N/A	20
NYXH Nyxoah	1.8909 of 5 stars	$3.08 +5.5%	$7.67 +148.9%	-62.9%	$113.18M	$10.02M	N/A	110	Gap Up
INO Inovio Pharmaceuticals	2.2546 of 5 stars	$1.30 -4.4%	$4.50 +246.2%	-31.5%	$111.89M	$60K	N/A	320	Gap Down
VANI Vivani Medical	3.8847 of 5 stars	$1.17 -2.5%	$3.50 +199.1%	+6.2%	$103.48M	N/A	N/A	20	Positive News Gap Down
LAKE Lakeland Industries	3.0047 of 5 stars	$9.53 -9.2%	$15.20 +59.5%	-42.8%	$103.41M	$192.65M	N/A	2,600	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PETV) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PetVivo (PETV) Competitors

PETV vs. NYXH, INO, VANI, LAKE, and SPAI

How does PetVivo compare to Nyxoah?

Summary

How does PetVivo compare to Inovio Pharmaceuticals?

Summary

How does PetVivo compare to Vivani Medical?

Summary

How does PetVivo compare to Lakeland Industries?

Summary

How does PetVivo compare to Safe Pro Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PetVivo (PETV) Competitors

PETV vs. NYXH, INO, VANI, LAKE, and SPAI

How does PetVivo compare to Nyxoah?

Does the media prefer PETV or NYXH?

Which has more volatility and risk, PETV or NYXH?

Do insiders & institutionals believe in PETV or NYXH?

Do analysts recommend PETV or NYXH?

Which has better earnings & valuation, PETV or NYXH?

Is PETV or NYXH more profitable?

Summary

How does PetVivo compare to Inovio Pharmaceuticals?

Which has stronger valuation & earnings, INO or PETV?

Which has more risk & volatility, INO or PETV?

Do insiders and institutionals have more ownership in INO or PETV?

Does the media refer more to INO or PETV?

Is INO or PETV more profitable?

Do analysts prefer INO or PETV?

Summary

How does PetVivo compare to Vivani Medical?

Is PETV or VANI more profitable?

Which has more volatility & risk, PETV or VANI?

Do institutionals & insiders hold more shares of PETV or VANI?

Which has preferable valuation and earnings, PETV or VANI?

Does the media favor PETV or VANI?

Do analysts prefer PETV or VANI?

Summary

How does PetVivo compare to Lakeland Industries?

Is PETV or LAKE more profitable?

Which has more volatility and risk, PETV or LAKE?

Do analysts prefer PETV or LAKE?

Which has higher earnings & valuation, PETV or LAKE?

Does the media refer more to PETV or LAKE?

Do institutionals and insiders have more ownership in PETV or LAKE?

Summary

How does PetVivo compare to Safe Pro Group?

Do analysts prefer PETV or SPAI?

Which has more risk & volatility, PETV or SPAI?

Is PETV or SPAI more profitable?

Which has preferable valuation & earnings, PETV or SPAI?

Do insiders and institutionals have more ownership in PETV or SPAI?

Does the media prefer PETV or SPAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools